13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001792206
Total reported value
$362.2M
$362.2M
7 檔
42.0%
At the close of Q4 2025, Foresite Capital Management V, LLC disclosed equity holdings valued at approximately $362.2M, spread across 7 reported holdings.
In Q4 2025, Foresite Capital Management V, LLC displayed an active expansion posture, initiating 1 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALMS | Alumis Inc | Stock-Other | 34.31% | -2.13% | — | |
| 2 | CGON | Cg Oncology Inc | Stock-Other | 25.36% | -3.91% | — | |
| 3 | IRON | Disc Medicine Inc | Stock-Other | 14.45% | -1.28% | — | |
| 4 | NTRA | Natera Inc | Stock-Healthcare | 9.39% | — | — | |
| 5 | LYEL | Lyell Immunopharma Inc | Stock-Other | 8.93% | -1.68% | — | |
| 6 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 5.39% | +1.42% | — | |
| 7 | MAZE | Maze Therapeutics Inc | Stock-Other | 2.17% | -0.29% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALMS | Alumis Inc | +13.1% | — | Unchanged |
| 2 | LYEL | Lyell Immunopharma Inc | +1.8% | — | Unchanged |
| 3 | MAZE | Maze Therapeutics Inc | +0.1% | — | Unchanged |
| 4 | IRON | Disc Medicine Inc | -3.7% | — | Unchanged |
| 5 | HIMS | Hims & Hers Health Inc | -8.9% | — | Unchanged |
| 6 | CGON | Cg Oncology Inc | -11.8% | — | Unchanged |
| 7 | NTRA | Natera Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Foresite Capital Management V, LLC reported a total U.S. public equity portfolio value of $362.2M across 7 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALMS, CGON, IRON) accounted for 42.0% of total reported equity market value during Q4 2025.
Top New Position Initiated
NTRA
市值: $15.4M
During Q4 2025, Foresite Capital Management V, LLC's top holdings by market value included ALMS (34.3%)、CGON (25.4%)、IRON (14.4%). The largest single position, ALMS, represented 34.3% of total portfolio value.
In Q4 2025, Foresite Capital Management V, LLC made 1 total portfolio adjustments, initiating 1 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.